1. Home
  2. PHGE vs GDHG Comparison

PHGE vs GDHG Comparison

Compare PHGE & GDHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • GDHG
  • Stock Information
  • Founded
  • PHGE 2015
  • GDHG 2008
  • Country
  • PHGE Israel
  • GDHG China
  • Employees
  • PHGE N/A
  • GDHG N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • GDHG Services-Misc. Amusement & Recreation
  • Sector
  • PHGE Health Care
  • GDHG Consumer Discretionary
  • Exchange
  • PHGE Nasdaq
  • GDHG Nasdaq
  • Market Cap
  • PHGE 13.3M
  • GDHG 11.0M
  • IPO Year
  • PHGE N/A
  • GDHG 2023
  • Fundamental
  • Price
  • PHGE $0.61
  • GDHG $0.29
  • Analyst Decision
  • PHGE Strong Buy
  • GDHG
  • Analyst Count
  • PHGE 2
  • GDHG 0
  • Target Price
  • PHGE $23.00
  • GDHG N/A
  • AVG Volume (30 Days)
  • PHGE 191.3K
  • GDHG 2.5M
  • Earning Date
  • PHGE 05-19-2025
  • GDHG 04-29-2025
  • Dividend Yield
  • PHGE N/A
  • GDHG N/A
  • EPS Growth
  • PHGE N/A
  • GDHG N/A
  • EPS
  • PHGE N/A
  • GDHG N/A
  • Revenue
  • PHGE N/A
  • GDHG $22,333,251.00
  • Revenue This Year
  • PHGE N/A
  • GDHG N/A
  • Revenue Next Year
  • PHGE N/A
  • GDHG N/A
  • P/E Ratio
  • PHGE N/A
  • GDHG N/A
  • Revenue Growth
  • PHGE N/A
  • GDHG N/A
  • 52 Week Low
  • PHGE $0.48
  • GDHG $0.25
  • 52 Week High
  • PHGE $4.99
  • GDHG $19.00
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 54.10
  • GDHG 37.54
  • Support Level
  • PHGE $0.52
  • GDHG $0.26
  • Resistance Level
  • PHGE $0.57
  • GDHG $0.35
  • Average True Range (ATR)
  • PHGE 0.05
  • GDHG 0.06
  • MACD
  • PHGE 0.01
  • GDHG -0.02
  • Stochastic Oscillator
  • PHGE 80.46
  • GDHG 16.52

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.

Share on Social Networks: